Author

Meghan C. Ferrall‐Fairbanks

University of FloridaORCID 0000-0002-3380-6989Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:clustering· 2 Research Focus:differential expression· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Approach:deep learning· 1

Frequent Co-Authors

Adriana Del Pino Herrera· 1 shared Chris A. KieslichiD· 1 shared Doan BuiiD· 1 shared Eric PadroniD· 1 shared Hyeju SongiD· 1 shared Isaac B. RheaiD· 1 shared Joon-Hyun SongiD· 1 shared Jowana Obeid· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adriana Del Pino Herrera

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Computational alternative to cardiac biopsy in multiple myeloma: utilizing the shape of routine laboratory data for the classification of AL cardiac amyloidosis

Maegan A. Cremer, Hyeju Song, Michael G. Fradley, Isaac B. Rhea, Chris A. Kieslich, Meghan C. Ferrall‐Fairbanks

The paper develops machine learning models to classify AL cardiac amyloidosis in multiple myeloma patients using electronic medical records instead of cardiac biopsy.

bioRxiv · Oct 30, 2026 · PreprintBioengineering

Single-cell RNA editing defines clinically relevant cellular states in chronic myelomonocytic leukemia

Nisansala Wickramasinghe, Doan Bui, Surendra Neupane, Meghan C. Ferrall‐Fairbanks, Michael W. Deininger, Eric Padron, Tongjun Gu

This study identifies RNA editing-defined cellular states in CMML that correlate with clinical outcomes and therapeutic response.

Haematologica · Sep 3, 2026Peer-reviewedCancer Biology

Metabolic plasticity increases evolvability and drives persistence to PARP inhibitor in ovarian cancer

Adriana Del Pino Herrera, Joon-Hyun Song, Karla Torres‐Arciga, Susoma Halder, Kadin El Bakkouri, Jowana Obeid, William M. Burke, Mehdi Damaghi, Meghan C. Ferrall-Fairbanks

Ovarian cancer cells exploit metabolic plasticity to increase their evolvability to persist PARP inhibitor treatment.

bioRxiv · Oct 8, 2025 · PreprintCancer Biology